Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma.

被引：2
|
作者：
Taylor, Matthew H.
Vogelzang, Nicholas J.
Cohn, Allen Lee
Stepan, Daniel E.
Shumaker, Robert Charles
Dutcus, Corina E.
Guo, Matthew
Schmidt, Emmett V.
Rasco, Drew W.
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Comprehens Canc Ctr Nevada, Las Vegas, NV USA
[3] US Oncol, Rocky Mt Canc Ctr, Denver, CO USA
[4] Eisai Inc, Woodcliff Lake, NJ USA
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] South Texas Accelerated Res Therapeut, San Antonio, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 08期
关键词：
D O I：
10.1200/JCO.2019.37.8_suppl.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma
    Davar, Diwakar
    Wang, Hong
    Chauvin, Joe-Marc
    Pagliano, Ornella
    Fourcade, Julien J.
    Ka, Mignane
    Menna, Carmine
    Rose, Amy
    Sander, Cindy
    Borhani, Amir A.
    Karunamurthy, Arivarasan
    Tarhini, Ahmad A.
    Tawbi, Hussein A.
    Zhao, Qing
    Moreno, Blanca H.
    Ebbinghaus, Scott
    Ibrahim, Nageatte
    Kirkwood, John M.
    Zarour, Hassane M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (35) : 3450 - +
  • [42] NeoPeLe: A phase II trial of neoadjuvant (NAT) pembrolizumab (Pembro) combined with lenvatinib (Lenva) in resectable stage III melanoma
    Long, G. V.
    Spillane, A. J.
    Pennington, T. E.
    Shannon, K. F.
    Stretch, J.
    Gonzalez, M.
    Saw, R. P. M.
    Lo, S. N.
    Scolyer, R. A.
    Menzies, A. M.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S906 - S907
  • [43] A phase I clinical trial investigating the telomerase vaccine UV1 in combination with pembrolizumab in patients with advanced melanoma.
    Zakharia, Yousef
    O'Day, Steven
    Rasch, Wenche
    Milhem, Mohammed M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Movva, Sujana
    Avutu, Viswatej
    Chi, Ping
    Dickson, Mark Andrew
    Gounder, Mrinal M.
    Kelly, Ciara Marie
    Keohan, Mary Louise
    Meyers, Paul A.
    Cohen, Seth M.
    Hensley, Martee Leigh
    Konner, Jason A.
    Schram, Alison M.
    Lefkowitz, Robert A.
    Erinjeri, Joseph Patrick
    Qin, Li-Xuan
    Salcito, Tiffany
    Seier, Kenneth
    Tap, William D.
    D'Angelo, Sandra P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Pembrolizumab plus lenvatinib combination therapy for advanced endometrial carcinoma
    Walker, Christopher A.
    Spirtos, Alexandra N.
    Miller, David S.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (04) : 361 - 368
  • [46] A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Movva, Sujana
    Avutu, Viswatej
    Chi, Ping
    Dickson, Mark Andrew
    Gounder, Mrinal M.
    Kelly, Ciara Marie
    Keohan, Mary Louise
    Nacev, Benjamin Alexander
    Rosenbaum, Evan
    Thornton, Katherine Anne
    Cohen, Seth M.
    Hensley, Martee Leigh
    Konner, Jason A.
    Schram, Alison M.
    Qin, Li-Xuan
    Lefkowitz, Robert A.
    Erinjeri, Joseph Patrick
    D'Angelo, Sandra P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
    Motzer, Robert
    Alekseev, Boris
    Rha, Sun-Young
    Porta, Camillo
    Eto, Masatoshi
    Powles, Thomas
    Gruenwald, Viktor
    Hutson, Thomas E.
    Kopyltsov, Evgeny
    Mendez-Vidal, Maria J.
    Kozlov, Vadim
    Alyasova, Anna
    Hong, Sung-Hoo
    Kapoor, Anil
    Alonso Gordoa, Teresa
    Merchan, Jaime R.
    Winquist, Eric
    Maroto, Pablo
    Goh, Jeffrey C.
    Kim, Miso
    Gurney, Howard
    Patel, Vijay
    Peer, Avivit
    Procopio, Giuseppe
    Takagi, Toshio
    Melichar, Bohuslav
    Rolland, Frederic
    De Giorgi, Ugo
    Wong, Shirley
    Bedke, Jens
    Schmidinger, Manuela
    Dutcus, Corina E.
    Smith, Alan D.
    Dutta, Lea
    Mody, Kalgi
    Perini, Rodolfo F.
    Xing, Dongyuan
    Choueiri, Toni K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (14): : 1289 - 1300
  • [48] Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
    Hunt, Jonathan T.
    Chambers, Laura M.
    Yao, Meng
    Joehlin-Price, Amy
    Debernardo, Robert
    Rose, Peter G.
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [49] KEYNOTE 029: A phase I/II randomized trial of pembrolizumab (pembro) plus 2 dose regimens of ipilimumab (ipi) for advanced melanoma
    Atkins, Michael B.
    Carlino, Matteo S.
    Hill, Andrew G.
    McNeil, Catriona M.
    Long, Georgina V.
    Atkinson, Victoria
    Cebon, Jonathan S.
    Jameson, Michael B.
    Hwu, Wen-Jen
    Thompson, John A.
    Anderson, James
    Moreno, Blanca Homet
    Ibrahim, Nageatte
    Ribas, Antoni
    [J]. CANCER RESEARCH, 2017, 77
  • [50] Pembrolizumab plus lenvatinib for all advanced endometrial cancer? Maybe not
    Paulino, Eduardo
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (04) : 579 - 579
12345